At @ weeks , the adjusted mean change in HbA@c from baseline was significantly reduced in the dapagliflozin @ mg twice daily and @mg twice daily groups versus placebo ( -@ vs. -@ % , p = @ and -@ % vs. -@ % , p < @ ) .